Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

20111,085 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 377, Issue 9769, pp. 914-923

Field-Weighted Citation Impact: 30.70